Treadmill Training With Additional Body Load: Effects on Gait of Subjects With Parkinson´s Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background: Studies about the effects of walking training with additional body load in Parkinson's disease (PD) are lacking. There is evidence that the increase of body load during treadmill walking improves reflex activity and leg extensor muscle activity, which are impaired in subjects with PD.
Purpose: The purpose of this study was to assess the effects of treadmill walking training with additional body load on the ground reaction forces, spatiotemporal, and kinematic variables of the gait of subjects with moderate PD.
Design: This study was an A1-B-A2 single-case. Setting: The evaluation and the training were conducted in a movement analysis laboratory, and at the rehabilitation unit of the University, respectively.
Participants: Nine patients with PD (Hoehn and Yahr 2 through 3) and gait disturbances.
Interventions: Phases A1 and A2 included 6 weeks of gait training on a treadmill with 10% increase of normal body mass. Phase B included 6 weeks of conventional physical therapy.
Measurements: Measures included the ground reaction forces, spatiotemporal, and kinematic variables during overground walking, at baseline and after each phase.
| Condition | Intervention |
|---|---|
|
Parkinson´s Disease |
Other: Treadmill walking training with additional body load |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
- Significant increase in propulsive forces, stride length, speed, maximum hip extension during stance were observed after the training program. [ Time Frame: 4 times, once before treatment, and 3 after each treatment phase. ] [ Designated as safety issue: No ]
| Enrollment: | 9 |
| Study Start Date: | August 2007 |
| Study Completion Date: | December 2008 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: PD Group
Nine subjects with idiopathic PD, previously diagnosed by one specialist physician participated in this study.
|
Other: Treadmill walking training with additional body load
The training program was divided into three phases (A1-B-A2): treadmill training with additional body load (A1), control condition (conventional physical therapy) (B). and treadmill training with additional body load again (A2). Each phase lasted six weeks, totaling 18 weeks. Both evaluations and training were performed during on-phase of the medication cycle. |
Eligibility| Ages Eligible for Study: | 51 Years to 81 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Idiopathic PD (previously diagnosed by one specialist physician,)
- Hoehn and Yahr (H-Y) stages 2 through 3,
- Absence of dementia (Mini-Mental Status Examination - MMSE, defined according to educational level) and,
- Capacity to ambulate independently for at least 10 meters.
Exclusion Criteria:
- Change medication (dopaminergic) during the study period,
- Use treadmill for at least six months prior to the study, and
- Other neurologic problems or musculoskeletal, cardiovascular and respiratory disease or uncorrected visual deficit that could represent risk and interfere in the performance of the training.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Nadiesca Taisa Filippin, Universidade Federal de Sao Carlos |
| ClinicalTrials.gov Identifier: | NCT00964652 History of Changes |
| Other Study ID Numbers: | 234/2007 |
| Study First Received: | August 24, 2009 |
| Last Updated: | August 24, 2009 |
| Health Authority: | Brazil: Ethics Committee |
Keywords provided by Universidade Federal de Sao Carlos:
|
treadmill body load Parkinson's disease gait |
Additional relevant MeSH terms:
|
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases |
ClinicalTrials.gov processed this record on May 23, 2013